Skip to main content

Oncolytics Bio(ONC-T)

Today's Change
Real-Time Last Update

Oncolytics Bio

322 11th Avenue S.W
Suite 804
Calgary AB T2R 0C5 CAN
P: 403-670-7377
F: 403-283-0858

Sectors & Indices



Oncolytics Biotech Inc is a development-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. Its clinical development plan has the approval of its products as quickly as possible and expands its products into commercially valuable new treatment areas as objectives. The primary focus is to advance programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies.

Key Executives

Andrew R. de GuttadauroOther Corporate Officer/President, Subsidiary
Matthew C. CoffeyCEO/Co-Founder/Director/President
Kirk J. LookCFO
Allison HagermanVice President, Divisional
Thomas C. HeinemanChief Medical Officer